KMT2A and leukemia: A reduction of MLL-AF9+ (GFP+) Gr1+ cells in BM (Supplementary Fig. 8d) and significant prolongation of survival (P = 0.0034, Fig. 3a) were also observed in recipients of Casr KO leukaemia-initiating cells (LIC).